MedTrace Logo

Large-scale Expansion and Characterization of Mesenchymal Stem Cells for Clinical Application

NCT02375568 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2015-03-02

No results posted yet for this study

Summary

According to many recent research, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis.

Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of total knee replacement. The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare the chondrogenesis ability for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)"

Conditions

  • Knee Injuries

Interventions

OTHER

103024-F

mesenchymal stem cell isolation

Sponsors & Collaborators

  • EMO Biomedicine Corporation

    collaborator INDUSTRY

  • Chin-Hung Chang

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02375568 on ClinicalTrials.gov